Hyperprogressive disease in non-small cell lung cancer after PD-1/PD-L1 inhibitors immunotherapy: underlying killer

por Li, Yanping, Chen, Tianhong, Nie, Tian Yi, Han, Juyuan, He, Yunyan, Tang, Xingxing, Zhang, Li
Publicado 2023